SANOFI INDIA
|
The Current P/S Ratio of SANOFI INDIA is 4.95.
| Share Price | ₹4,158.6 | Jan 16,2026 |
| Market Cap | ₹9,564.8 Cr | |
| Sales-TTM | ₹1,932.5 Cr | TTM-Standalone Results |
| Price/Sales | 4.95x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SANOFI INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹9,564.8 Cr] as on Jan 16,2026
(/) Sales [ ₹1,932.5 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 4.95x ]
Thus, for SANOFI INDIA , the investors are currently willing to pay '4.95 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SANOFI INDIA !
The chart below summarizes the trend in P/S Ratio of SANOFI INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of SANOFI INDIA
PS Ratio Performance Analysis for SANOFI INDIA
- SANOFI INDIA 's p/e ratio for fiscal years ending Dec2024 to Dec2020 averaged 6.78x.
- SANOFI INDIA 's operated at median p/e ratio of 6.59x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SANOFI INDIA 's p/e ratio peaked in Dec2023 at 9.3x.
- SANOFI INDIA 's p/e ratio hit its five-year low in Dec2022 of 4.86x.
How does SANOFI INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SANOFI INDIA | 1,932.5 | 4.95 | 9,564.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.29 | 400,497.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 16.50 | 165,492.0 |
| CIPLA LTD | 28,349.6 | 3.98 | 112,922.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 11.10 | 136,013.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.86 | 98,115.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.62 | 89,832.6 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.57 | 87,321.0 |
| LUPIN LTD | 24,750.7 | 4.02 | 99,410.8 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.09 | 68,087.4 |
| ABBOTT INDIA LTD | 6,714.4 | 8.79 | 59,024.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SANOFI INDIA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.09x |
| Max industry PS | 16.50x |
| Median industry PS | 4.95x |
| Average industry PS | 6.52x |
You may also like the below Video Courses